Hat mitgewirkt an:
-
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
-
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
-
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
-
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia